VERY LOW-CARBOHYDRATE KETOGENIC DIET FOR THE TREATMENT OF SEVERE OBESITY AND ASSOCIATED NON-ALCOHOLIC FATTY LIVER DISEASE: THE ROLE OF SEX DIFFERENCES

التفاصيل البيبلوغرافية
العنوان: VERY LOW-CARBOHYDRATE KETOGENIC DIET FOR THE TREATMENT OF SEVERE OBESITY AND ASSOCIATED NON-ALCOHOLIC FATTY LIVER DISEASE: THE ROLE OF SEX DIFFERENCES
المؤلفون: Giacomo Pucci, E. Nulli Migliola, G. Vaudo, Stefano Ministrini, Vito Gandolfo, Marco D’Abbondanza, Graziana Lupattelli, Donatella Siepi, Maria Teresa Paganelli, Eva-Edvige Martorelli
المصدر: Nutrition. :111327
بيانات النشر: Elsevier BV, 2021.
سنة النشر: 2021
مصطلحات موضوعية: Sleeve gastrectomy, Nutrition and Dietetics, medicine.diagnostic_test, business.industry, Endocrinology, Diabetes and Metabolism, medicine.medical_treatment, Fatty liver, Physiology, medicine.disease, Comorbidity, Menopause, Weight loss, medicine, Glucose homeostasis, medicine.symptom, Liver function tests, business, Ketogenic diet
الوصف: Objective Very low-carbohydrate ketogenic diets (VLCKDs) are a new type of weight loss (WL) intervention for severe obesity and are associated with a significant improvement in non-alcoholic fatty liver disease (NAFLD).Little is known about the effect of sex differences on weight loss induced by following a VLCKD.The aim of this study was to investigate the effects of sex differences on weight loss and NAFLD improvement in patients with severe obesity undergoing a VLCKD. Methods and procedures Seventy-three patients (42 females and 28males) with morbid obesity (BMI 40kg/m2 or 35 kg/m2+comorbidity) eligible for sleeve gastrectomy underwent a 25-day-long VLCKD.Anthropometric parameters, peripheral BP, bioimpedentiometry, degree of liver steatosis measured by ultrasonography, liver function tests, and glucose homeostasis were measured before and after the VLCKD. Results Males experienced a significantly larger excess body weight loss (EBWL, 14.5 vs11.7% respectively,p=0.018) and a greater reduction in y-glutamyl transferase (ϒ-GT, 17 vs6 IU/L respectively,p=0.003) than females. Dividing the female group by menopausal status, a significant difference between males and pre-menopausal females was found for both EBWL (14.5 vs10.8% respectively,p=0.017) and ϒ-GT (17 vs3 IU/L respectively,p Conclusion The efficacy of VLCKD in severe obesity is influenced by sex differences and, for females, by menopausal status. Males seem to experience larger benefits than females in terms of EBWL and NAFLD improvement. These differences seems attenuated after menopause, probably because of changes in hormonal profile and body composition.
تدمد: 0899-9007
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::4269d771f448c53b223059b4372d4fc5
https://doi.org/10.1016/j.nut.2021.111327
حقوق: CLOSED
رقم الأكسشن: edsair.doi...........4269d771f448c53b223059b4372d4fc5
قاعدة البيانات: OpenAIRE